{
    "xml": "<topic id=\"PHP8420\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/varicella-zoster-vaccine\" basename=\"varicella-zoster-vaccine\" title=\"VARICELLA-ZOSTER VACCINE\">\n<title>VARICELLA-ZOSTER VACCINE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1223\" namespace=\"/interactions/list-of-drug-interactions/vaccines/varicella-zoster-vaccine\">Varicella-zoster Vaccine</xref>\n</p>\n<data name=\"vtmid\">108729007</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_581448509\" title=\"Vaccines\">Vaccines</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34568\" title=\"VACCINES\" namespace=\"/drug-classes/vaccines\">VACCINES</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP52138\" outputclass=\"cautions\" rev=\"1.14\" parent=\"/drugs/varicella-zoster-vaccine\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Post-vaccination close contact with susceptible individuals</ph>\n</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p>Rarely, the varicella&#8211;zoster vaccine virus has been transmitted from the vaccinated individual to close contacts. Therefore, contact with the following should be avoided if a vaccine-related cutaneous rash develops within 4&#8211;6 weeks of the first or second dose:</p>\n<ul>\n<li>varicella-susceptible pregnant women;</li>\n<li>individuals at high risk of severe varicella, including those with immunodeficiency or those receiving immunosuppressive therapy.</li>\n</ul>\n<p>Healthcare workers who develop a generalised papular or vesicular rash on vaccination should avoid contact with patients until the lesions have crusted. Those who develop a localised rash after vaccination should cover the lesions and be allowed to continue working unless in contact with patients at high risk of severe varicella.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Administration with MMR vaccine</p>\n<p>Varicella&#8211;zoster and MMR vaccines can be given on the same day or separated by a 4-week minimum interval. When protection is rapidly required, the vaccines can be given at any interval and an additional dose of the vaccine given second may be considered.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP51953\" outputclass=\"sideEffects\" rev=\"1.11\" parent=\"/drugs/varicella-zoster-vaccine\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Thrombocytopenia</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Conjunctivitis</ph>; <ph outputclass=\"sideEffect\">varicella-like rash</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52111\" outputclass=\"conceptionAndContraception\" parent=\"/drugs/varicella-zoster-vaccine\">\n<title>Conception and contraception</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid pregnancy for 3 months after vaccination.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP8420-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/varicella-zoster-vaccine\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74638\" title=\"Powder and solvent for solution for injection\" namespace=\"/drugs/varicella-zoster-vaccine/powder-and-solvent-for-solution-for-injection\">Powder and solvent for solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74650\" title=\"Powder and solvent for suspension for injection\" namespace=\"/drugs/varicella-zoster-vaccine/powder-and-solvent-for-suspension-for-injection\">Powder and solvent for suspension for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78196\" namespace=\"/treatment-summaries/immunoglobulins\" title=\"Immunoglobulins\" count=\"1\" rel=\"backlink\">Immunoglobulins</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78335\" namespace=\"/treatment-summaries/vaccines\" title=\"Vaccines\" count=\"4\" rel=\"backlink\">Vaccines</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1223\" namespace=\"/interactions/list-of-drug-interactions/vaccines/varicella-zoster-vaccine\" title=\"Varicella-zoster Vaccine\" count=\"1\" rel=\"link\">Varicella-zoster Vaccine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34568\" namespace=\"/drug-classes/vaccines\" title=\"VACCINES\" count=\"1\" rel=\"link\">VACCINES</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74638\" namespace=\"/drugs/varicella-zoster-vaccine/powder-and-solvent-for-solution-for-injection\" title=\"Powder and solvent for solution for injection\" count=\"1\" rel=\"link\">Powder and solvent for solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74650\" namespace=\"/drugs/varicella-zoster-vaccine/powder-and-solvent-for-suspension-for-injection\" title=\"Powder and solvent for suspension for injection\" count=\"1\" rel=\"link\">Powder and solvent for suspension for injection</xref>\n</links>\n</topic>",
    "id": "PHP8420",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/varicella-zoster-vaccine",
    "basename": "varicella-zoster-vaccine",
    "title": "VARICELLA-ZOSTER VACCINE",
    "interactants": [
        {
            "id": "bnf_int_1223",
            "label": "Varicella-zoster Vaccine"
        }
    ],
    "vtmid": "108729007",
    "drugClassification": [
        "Vaccines"
    ],
    "inheritsFromClass": [
        "VACCINES"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Post-vaccination close contact with susceptible individuals",
                "html": "Post-vaccination close contact with susceptible individuals"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "textContent": "Rarely, the varicella&#8211;zoster vaccine virus has been transmitted from the vaccinated individual to close contacts. Therefore, contact with the following should be avoided if a vaccine-related cutaneous rash develops within 4&#8211;6 weeks of the first or second dose:\n\nvaricella-susceptible pregnant women; individuals at high risk of severe varicella, including those with immunodeficiency or those receiving immunosuppressive therapy.\n\nHealthcare workers who develop a generalised papular or vesicular rash on vaccination should avoid contact with patients until the lesions have crusted. Those who develop a localised rash after vaccination should cover the lesions and be allowed to continue working unless in contact with patients at high risk of severe varicella.",
                "html": "<p>Rarely, the varicella&#8211;zoster vaccine virus has been transmitted from the vaccinated individual to close contacts. Therefore, contact with the following should be avoided if a vaccine-related cutaneous rash develops within 4&#8211;6 weeks of the first or second dose:</p><ul>\n<li>varicella-susceptible pregnant women;</li>\n<li>individuals at high risk of severe varicella, including those with immunodeficiency or those receiving immunosuppressive therapy.</li>\n</ul><p>Healthcare workers who develop a generalised papular or vesicular rash on vaccination should avoid contact with patients until the lesions have crusted. Those who develop a localised rash after vaccination should cover the lesions and be allowed to continue working unless in contact with patients at high risk of severe varicella.</p>"
            },
            {
                "type": "importantAdvice",
                "title": "Administration with MMR vaccine",
                "textContent": "Varicella&#8211;zoster and MMR vaccines can be given on the same day or separated by a 4-week minimum interval. When protection is rapidly required, the vaccines can be given at any interval and an additional dose of the vaccine given second may be considered.",
                "html": "<p>Varicella&#8211;zoster and MMR vaccines can be given on the same day or separated by a 4-week minimum interval. When protection is rapidly required, the vaccines can be given at any interval and an additional dose of the vaccine given second may be considered.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Thrombocytopenia",
                        "html": "Thrombocytopenia",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Conjunctivitis",
                        "html": "Conjunctivitis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "varicella-like rash",
                        "html": "varicella-like rash",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "conceptionAndContraception": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid pregnancy for 3 months after vaccination.",
                "html": "<p>Avoid pregnancy for 3 months after vaccination.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP74638",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74650",
                "label": "Powder and solvent for suspension for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78196",
                "label": "Immunoglobulins",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78335",
                "label": "Vaccines",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1223",
                "label": "Varicella-zoster Vaccine",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34568",
                "label": "VACCINES",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP74638",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74650",
                "label": "Powder and solvent for suspension for injection",
                "type": "medicinalForm"
            }
        ]
    }
}